- Report
- March 2025
- 105 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Report
- November 2024
- 120 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Report
- May 2024
- 95 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Report
- February 2024
- 103 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Report
- February 2024
- 91 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Report
- February 2022
- 87 Pages
Global
From €3200EUR$3,745USD£2,815GBP
- Report
- January 2025
- 132 Pages
Global
From €870EUR$950USD£739GBP
- Report
- January 2025
- 132 Pages
Global
From €870EUR$950USD£739GBP
- Report
- January 2025
- 132 Pages
Global
From €870EUR$950USD£739GBP
- Book
- June 2020
- 198 Pages
- Report
- November 2021
- 527 Pages
Global
From €3662EUR$4,000USD£3,112GBP
- Report
- November 2021
- 802 Pages
Global
From €4577EUR$5,000USD£3,890GBP
- Report
- November 2021
- 1184 Pages
Global
From €5492EUR$6,000USD£4,668GBP
- Report
- November 2021
- 1165 Pages
Global
From €5492EUR$6,000USD£4,668GBP
- Report
- May 2023
- 216 Pages
Global
From €2288EUR$2,499USD£1,944GBP
€3268EUR$3,570USD£2,777GBP
- Report
- May 2023
- 274 Pages
Global
From €2288EUR$2,499USD£1,944GBP
€3268EUR$3,570USD£2,777GBP
- Report
- February 2023
- 427 Pages
Global
From €2288EUR$2,499USD£1,944GBP
€3268EUR$3,570USD£2,777GBP
- Report
- June 2022
- 297 Pages
Global
From €2215EUR$2,419USD£1,882GBP
€3164EUR$3,456USD£2,689GBP
- Report
- April 2022
- 262 Pages
Global
From €2215EUR$2,419USD£1,882GBP
€3164EUR$3,456USD£2,689GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more